As the COVID-19 pandemic surges ahead, researchers are desperately seeking evidence to support a range of potential disease modifying treatments. 

On this episode, Prof Tony Gordon from Imperial Hospitals in London joins me to discuss one such potential therapy, convalescent serum.  Tony is a prominent intensivist researcher and is the UK chief investigator for the REMAP-CAP study.

See omnystudio.com/listener for privacy information.